Amylyx Pharmaceuticals, Inc. (AMLX)
38.14
-0.52
(-1.35%)
USD |
NASDAQ |
Aug 24, 16:00
38.14
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Total Assets (Quarterly) : 264.56M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 264.56M |
| March 31, 2026 | 293.60M |
| December 31, 2025 | 334.07M |
| September 30, 2025 | 362.74M |
| June 30, 2025 | 194.60M |
| March 31, 2025 | 219.68M |
| December 31, 2024 | 193.63M |
| September 30, 2024 | 250.71M |
| June 30, 2024 | 332.16M |
| March 31, 2024 | 417.46M |
| December 31, 2023 | 517.45M |
| September 30, 2023 | 466.58M |
| Date | Value |
|---|---|
| June 30, 2023 | 453.59M |
| March 31, 2023 | 407.96M |
| December 31, 2022 | 391.45M |
| September 30, 2022 | 181.44M |
| June 30, 2022 | 225.24M |
| March 31, 2022 | 274.44M |
| December 31, 2021 | 105.61M |
| September 30, 2021 | 130.46M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 14.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 201.13B |
| Eli Lilly & Co. | 142.28B |
| Merck & Co., Inc. | 129.80B |
| EyePoint, Inc. | 228.19M |
| Bristol Myers Squibb Co. | 87.63B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 25.40M |
| Shareholders Equity (Quarterly) | 239.17M |
| Debt to Equity Ratio | 0.022 |
| Current Ratio | 12.12 |
| Net Debt Paydown Yield | -0.04% |